Total RNA Purification Kits
For research use only and NOT intended for in vitro diagnostics.
CE-IVDR marked diagnostic version available here
For research use only and NOT intended for in vitro diagnostics.
CE-IVDR marked diagnostic version available here
Register today to receive an exclusive 15% off* on your first order.
These kits are suitable for the isolation of total RNA from a range of samples including cells, bacteria, yeast, virus and bodily fluids including plasma/serum, blood, saliva, CSF and more. Extract high quality and purity RNA with excellent RIN values and A260/A280 suitable for downstream applications including qRT-PCR, RT-PCR, microarrays, NGS and more. These kits purify all sizes of RNA from large mRNA, lncRNA down to microRNA (miRNA) in the same fraction without the requirement of phenol. Isolate all RNA sequences at an equal rate irrespective of size. Moreover, when the RNA sequences are small (e.g. miRNA), the column binds small RNAs regardless of their GC content.
Total RNA Purification 96-Well Kit (High Throughput and High Throughput Deep Well)
This 96-well kit provides a rapid method for the high-throughput isolation and purification of total RNA in 30 minutes using vacuum manifold, plate centrifuge, or liquid handlers with vacuum capabilities. Total RNA can be isolated from a broad range of sample sources including cultured cells, tissues, blood, serum, plasma, bacteria, yeast, fungi, and viruses.
Isolate RNA after Purifying EVs and Exosomes
Ultracentrifugation, Exoquick, Filtration
Cat. # | Name | Elution Volume | Plasma/Serum | Urine | Cell-Culture Media |
---|---|---|---|---|---|
55000 | Plasma/Serum RNA Purification Mini Kit | 10 - 25 µL | 50 µL - 1 mL | 250 µL - 1 mL | 5 - 10 mL |
35300 | Total RNA Purification Micro Kit | 20 - 50 µL | 1 - 4 mL | 2 - 10 mL | 10 - 20 mL |
17200 | Total RNA Purification Kit | 50 - 100 µL | 4 - 10 mL | 11 - 30 mL | 20 - 35 mL |
Kit Specifications
|
|
Maximum Binding Capacity
|
Up to 50 μg RNA
|
Maximum Loading Volume
|
650 μL
|
Size of RNA Purified
|
All sizes, including small RNA (< 200 nt)
|
Maximum Amount of Starting Material
|
|
Animal Cells | 3 x 106 cells |
Animal Tissues | 10 mg (for most tissues*) |
Blood | 100 μL |
Plasma/Serum | 200 μL |
Bacteria | 1 x 109 cells |
Yeast |
1 x 108 cells
|
Fungi |
50 mg
|
Plant Tissues |
50 mg
|
Time to Complete 10 Purifications |
20 minutes
|
Average Yield | |
HeLa Cells (1 x 106 cells) | 15 μg |
E. coli (1 x 109 cells) | 50 μg |
* for isolating total RNA from larger amounts of tissue, please use Norgen's Animal Tissue RNA Purification Kit (Cat# 25700)
Storage Conditions and Product Stability
All solutions should be kept tightly sealed and stored at room temperature. These kits are stable for 2 years after the date of shipment.
Component | Cat. 17200 (50 preps) | Cat. 37500 (100 preps) | Cat. 17250 (250 preps) | Cat. 17270 (500 preps) | Cat. 24300 (192 preps) | Cat. 24370 (576 preps) | Cat. 24350 (192 preps) | Cat. 24380 (576 preps) |
---|---|---|---|---|---|---|---|---|
Buffer RL | 40 mL | 2 x 40 mL | 175 mL | 350 mL | 2 x 40 mL | 350 mL | 2 x 40 mL | 350 mL |
Wash Solution A | 38 mL | 2 x 38 mL | 148 mL | 1 x 148 mL 1 x 74 mL |
2 x 38 mL | 1 x 74 mL 1 x 148 mL |
2 x 38 mL | 1 x 74 mL 1 x 148 mL |
Elution Solution A | 6 mL | 2 x 6 mL | 30 mL | 60 mL | 2 x 20 mL | 60 mL | 2 x 20 mL | 60 mL |
Mini Spin Columns | 50 | 100 | 250 | 500 | - | - | - | - |
96-Well Isolation Plate | - | - | - | - | 2 | 6 | - | - |
96-Well Isolation Plate (Deep Well) | - | - | - | - | - | - | 2 | 6 |
Adhesive Tape | - | - | - | - | 4 | 12 | 4 | 12 |
Collection Tubes | 50 | 100 | 250 | 500 | - | - | ||
96-Well Collection Plate | - | - | - | - | 2 | 6 | - | - |
96-Well Collection Plate (Deep Well) | - | - | - | - | - | - | 2 | 6 |
Elution Tubes (1.7 mL) | 50 | 100 | 250 | 500 | - | - | ||
96-Well Elution Plate | - | - | - | - | 2 | 6 | - | - |
96-Well Elution Plate (Deep Well) | - | - | - | - | - | - | 2 | 6 |
Product Insert | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
Poor RNA recovery could be due to one or more of the following:
Column/well clogging can result from one or combination of the following factors:
RNA can be degraded due to the following factors:
If the RNA does not perform well in downstream applications, it may be due to one or more of the following:
The contamination with genomic DNA may be due to large amount of starting material used. Perform RNase-free DNase I digestion on the RNA sample after elution to remove genomic DNA contamination. It is recommended that Norgen’s RNase-Free DNase I Kit (Product # 25710) be used for this step.
Yes, the Total RNA purification kits can be used to purify RNA from samples like buffy coats and isolated PBMCs. For blood leukocyte samples, you can use a specialized product - Leukocyte RNA purification kit.
Yes, Total RNA purification kits can be used with samples stored in RNA protective agents like RNAlater. Norgen Biotek also provides a similar RNA preserve solution (Cat. 17260).
Yes, you can use Total RNA purification kits to purify RNA from insect samples. Please contact our Tech support team at support@norgenbiotek.com and ask for reference publications.
Yes, lysates prepared in buffer RL can be frozen at -80°C, and the remaining protocol can be performed at a later date.
Yes, you can use Norgen's Total RNA purification kits with the aqueous phase from samples prepared in TRIzol. Please contact our Tech Support team at support@norgenbiotek.com if you have any questions regarding the protocol.
Yes, Norgen Total RNA purification kits are compatible with tissue samples stored in OCT compound. Please contact our Tech Support team at support@norgenbiotek.com and ask for reference publications.
Title | Veronica Ramos-Mejia1, Gustavo J Melen1, Laura Sanchez1, Ivan Gutierrez-Aranda1, Gertrudis Ligero1, Jose L Cortes1, Pedro J Real1, Clara Bueno1 and Pablo Menendez1 |
Citation | Mol Ther. 2010 Aug 24 2010. |
Authors | Veronica Ramos-Mejia1, Gustavo J Melen1, Laura Sanchez1, Ivan Gutierrez-Aranda1, Gertrudis Ligero1, Jose L Cortes1, Pedro J Real1, Clara Bueno1 and Pablo Menendez1 |
Title | Direct conversion of human fibroblasts to multilineage blood progenitors. |
Citation | Nature. 2010. 2010. |
Authors | Szabo E, Rampalli S, Risueño RM, Schnerch A, Mitchell R, Fiebig-Comyn A, Levadoux-Martin M, Bhatia M. |
Title | MHC class II DRB diversity in raccoons (Procyon lotor) reveals associations with raccoon rabies virus (Lyssavirus) |
Citation | Immunogenetics, Sept 201 2010. |
Authors | Vythegi Srithayakumar & Sarrah Castillo & Rick C. Rosatte & Christopher J. Kyle |
Title | Tritrichomonas fetus extracellular products decrease progressive motility of bull sperm |
Citation | Theriogenology, Volume 73, Issue 1, Pages 64-70 2010. |
Authors | C. Ribeiro, M. Falleiros, S. Bicudo, J. Júnior, M. Golim, F. Filho, C. Padovani, J. Modolo |
Title | Live cell imaging reveals continuous STAT6 Nuclear Trafficking |
Citation | Journal of Immunology 2010. |
Authors | Hui-Chen Chen and Nancy C. Reich |
Title | 8q24 prostate, breast, and colon cancer risk loci show tissue-specific long-range interaction with MYC |
Citation | PNAS 2010. |
Authors | Nasim Ahmadiyeha,b, Mark M. Pomerantza, Chiara Grisanzioa, Paula Hermana, Li Jiac, Vanessa Almendroa, Housheng Hansen Hea,d, Myles Browna, X. Shirley Liua,d, Matt Davisa, Jennifer L. Caswella, Christine A. Beckwitha, Adam Hillsa, Laura MacConailla, Gerhard A. Coetzeee, Meredith M. Regand, and Matthew L. Freedmana,f,1 |
Title | stem cells cause resistance to Kit/Pdgfra inhibitors in murine gastrointestinal stromal tumors |
Citation | Gastroenterology 2010. |
Authors | Michael R. Bardsley, Viktor J. Horváth, David T. Asuzu, Andrea Lorincz, Doug Redelman, Yujiro Hayashi, Laura N. Popko, David L. Young, Gwen A. Lomberk, Raul A. Urrutia, Gianrico Farrugia, Brian P. Rubin, Tamas Ordog |
Title | Molecular characterization of seven genes encoding ethylene-responsive transcriptional factors during plum fruit development and ripening |
Citation | J. Exp. Bot., March 2009; 60: 907 - 922. 2009. |
Authors | El-Sharkawy, S. Sherif, I. Mila, M. Bouzayen, and S. Jayasankar |
Title | MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis |
Citation | PLoS One 2009. |
Authors | Catalin Vasilescu1., Simona Rossi2., Masayoshi Shimizu2, Stefan Tudor1, Angelo Veronese3, Manuela Ferracin3, Milena S. Nicoloso2, Elisa Barbarotto2, Monica Popa1, Oana Stanciulea1, Michael H. Fernandez4, Dan Tulbure5, Carlos E. Bueso-Ramos4, Massimo Negrini3, George A. Calin2* |
Title | The quadruplex r(CGG)n destabilizing cationic porphyrin TMPyP4 cooperates with hnRNPs to increase the translation efficiency of fragile X premutation mRNA |
Citation | Nucleic Acids Research, 2009, 1-11 2009. |
Authors | Noa Ofer, Pnina Weisman-Shomer, Jeny Shklover and Michael Fry* |